CoChat

The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: the microparticle‐associated immune complexes

Open access

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Abstract

Immunoglobulins, antigens and complement can assemble to form immune complexes (IC). ICs can be detrimental as they propagate inflammation in autoimmune diseases. Like ICs, submicron extracellular vesicles termed microparticles (MP) are present in the synovial fluid from patients affected with autoimmune arthritis. We examined MPs in rheumatoid arthritis (RA) using high sensitivity flow cytometry and electron microscopy. We find that the MPs in RA synovial fluid are highly heterogeneous in size. The observed larger MPs were in fact MP‐containing ICs (mpICs) and account for the majority of the detectable ICs. These mpICs frequently express the integrin CD41, consistent with platelet origin. Despite expression of the Fc receptor FcγRIIa by platelet‐derived MPs, we find that the mpICs form independently of this receptor. Rather, mpICs display autoantigens vimentin and fibrinogen, and recognition of these targets by anti‐citrullinated peptide antibodies contributes to the production of mpICs. Functionally, platelet mpICs are highly pro‐inflammatory, eliciting leukotriene production by neutrophils. Taken together, our data suggest a unique role for platelet MPs as autoantigen‐expressing elements capable of perpetuating formation of inflammatory ICs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201201846

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MPs are heterogeneous in size and are more abundant in RA compared to PA SF A. Acquisition of fluorescent Sky Blue microspheres of 40–90 nm (mean = 90 nm, in cyan blue), 100–300 nm (mean = 220 nm, in pink), 400–600 nm (mean = 450 nm, in green), 700–900 nm (mean = 840 nm, in blue), 2500–4500 nm (mean = 3200 nm, in violet) diameter on a flow cytometer Canto II modified with a FSC-PMT small particles option. A scale bar ranging from 100 to 3200 nm based on the microsphere sizes (FSC-PMT) is presented and used to determine the relative dimensions of the MPs.B,C. Representative FSC-PMT and SSC portrayals of the Annexin-V+ events detected in RA SF (B) and PA SF (C) revealing the dimension diversity of the MPs. The relative dimensions of the MPs are presented according to size-defined microsphere calibrations. Two major subpopulations (subpop 1 and 2) are detected in RA SF (B) while only one (subpop 1) is observed in PA SF (C) are identified on the graphs.D. Triton sensitivity of the MPs in RA SF detected using Annexin-V labeling presented as % of untreated (control).E. Flow cytometric quantifications of the Annexin-V+ MPs contained in RA and PA SF (n = 23 RA and n = 18 PA ***p = 0.0004). Statistical analyses are presented under the graph. Data are mean ± SEM.
Figure 1 MPs are heterogeneous in size and are more abundant in RA compared to PA SF A. Acquisition of fluorescent Sky Blue microspheres of 40–90 nm (mean = 90 nm, in cyan blue), 100–300 nm (mean = 220 nm, in pink), 400–600 nm (mean = 450 nm, in green), 700–900 nm (mean = 840 nm, in blue), 2500–4500 nm (mean = 3200 nm, in violet) diameter on a flow cytometer Canto II modified with a FSC-PMT small particles option. A scale bar ranging from 100 to 3200 nm based on the microsphere sizes (FSC-PMT) is presented and used to determine the relative dimensions of the MPs.B,C. Representative FSC-PMT and SSC portrayals of the Annexin-V+ events detected in RA SF (B) and PA SF (C) revealing the dimension diversity of the MPs. The relative dimensions of the MPs are presented according to size-defined microsphere calibrations. Two major subpopulations (subpop 1 and 2) are detected in RA SF (B) while only one (subpop 1) is observed in PA SF (C) are identified on the graphs.D. Triton sensitivity of the MPs in RA SF detected using Annexin-V labeling presented as % of untreated (control).E. Flow cytometric quantifications of the Annexin-V+ MPs contained in RA and PA SF (n = 23 RA and n = 18 PA ***p = 0.0004). Statistical analyses are presented under the graph. Data are mean ± SEM.CC BY · PubMed Central
Figure 2 Visualization of the mpICs in RA SF Cryo-TEM detection of immunoglobulins and phosphatidylserine exposing MPs using, respectively protein A-conjugated gold nanoparticles (10 nm) and Annexin-V-conjugated gold nanoparticles (4 nm). A,B. Representative observations obtained using RA SF in which MPs [white boxes labelled MP (MP 1 and MP 2 (A) and MP (B)] were colocalized with ∼2 µm diameter mpICs. White arrows indicate the edge of the IC where MPs were detected. Black arrows indicate the carbon matrix of the perforated support film used for TEM. Insets (bottom panels) include individual MPs. Immunoglobulins detected using protein A conjugated nanospheres (10 nm) are indicated with white arrowheads and MPs detected using Annexin-V conjugated nanospheres (4 nm) are indicated by black arrowheads. Note that some MPs were Annexin-V negative.C. Relatively smaller mpICs were also visualized. White and black arrowheads indicate immunoglobulins and phosphatidylserine, respectively. Scale bars are presented under each panel.
Figure 2 Visualization of the mpICs in RA SF Cryo-TEM detection of immunoglobulins and phosphatidylserine exposing MPs using, respectively protein A-conjugated gold nanoparticles (10 nm) and Annexin-V-conjugated gold nanoparticles (4 nm). A,B. Representative observations obtained using RA SF in which MPs [white boxes labelled MP (MP 1 and MP 2 (A) and MP (B)] were colocalized with ∼2 µm diameter mpICs. White arrows indicate the edge of the IC where MPs were detected. Black arrows indicate the carbon matrix of the perforated support film used for TEM. Insets (bottom panels) include individual MPs. Immunoglobulins detected using protein A conjugated nanospheres (10 nm) are indicated with white arrowheads and MPs detected using Annexin-V conjugated nanospheres (4 nm) are indicated by black arrowheads. Note that some MPs were Annexin-V negative.C. Relatively smaller mpICs were also visualized. White and black arrowheads indicate immunoglobulins and phosphatidylserine, respectively. Scale bars are presented under each panel.CC BY · PubMed Central
Figure 3 MPs, including platelet MPs, in RA SF form mpICs FSC-PMT and SSC dot plots of representative RA SF labelled with a combination of FITC-conjugated Annexin-V and Cy5-conjugated anti-IgG to demonstrate the presence of IgG on surface of Annexin-V+ MPs. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) in blue show dimensions ranging mostly from 100 to 300 nm (lower inset) while the mpICs (Annexin-V+-IgG+) in green have dimensions from 700 to 3000 nm (upper inset). The relative diameters are presented according to size-defined microsphere calibrations.Quantifications of the mpICs contained in RA and PA SF (n = 23 RA and n = 18 PA ***p < 0.0001).Quantifications of the mpICs relative to the total amounts of detectable ICs in RA SF (n = 23). The statistical analyses are presented under each graph. Data are mean ± SEM.FSC-PMT and SSC dot plots of representative PA SF labelled with a combination of FITC-conjugated Annexin-V and Cy5-conjugated anti-IgG.FSC-PMT and SSC dot plots of RA SF patients labelled with PE-conjugated anti-CD41 and Cy5-conjugated anti-IgG. The four-quadrant gates were positioned according to the isotypic controls. The presence of CD41+ mpICs is evidenced by the dual expression of CD41 and IgG by MPs (green region). RA SF from two patients are presented to illustrate the heterogeneity that exists among the patients.Quantifications of the CD41+ mpICs in RA and PA SF (n = 25 RA and n = 18 PA ***p = 0.0006). The statistical analyses are presented under each graph. Data are mean ± SEM.Triton sensitivity of the CD41+ mpICs contained in RA SF presented as % of untreated (control) CD41+ mpICs.
Figure 3 MPs, including platelet MPs, in RA SF form mpICs FSC-PMT and SSC dot plots of representative RA SF labelled with a combination of FITC-conjugated Annexin-V and Cy5-conjugated anti-IgG to demonstrate the presence of IgG on surface of Annexin-V+ MPs. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) in blue show dimensions ranging mostly from 100 to 300 nm (lower inset) while the mpICs (Annexin-V+-IgG+) in green have dimensions from 700 to 3000 nm (upper inset). The relative diameters are presented according to size-defined microsphere calibrations.Quantifications of the mpICs contained in RA and PA SF (n = 23 RA and n = 18 PA ***p < 0.0001).Quantifications of the mpICs relative to the total amounts of detectable ICs in RA SF (n = 23). The statistical analyses are presented under each graph. Data are mean ± SEM.FSC-PMT and SSC dot plots of representative PA SF labelled with a combination of FITC-conjugated Annexin-V and Cy5-conjugated anti-IgG.FSC-PMT and SSC dot plots of RA SF patients labelled with PE-conjugated anti-CD41 and Cy5-conjugated anti-IgG. The four-quadrant gates were positioned according to the isotypic controls. The presence of CD41+ mpICs is evidenced by the dual expression of CD41 and IgG by MPs (green region). RA SF from two patients are presented to illustrate the heterogeneity that exists among the patients.Quantifications of the CD41+ mpICs in RA and PA SF (n = 25 RA and n = 18 PA ***p = 0.0006). The statistical analyses are presented under each graph. Data are mean ± SEM.Triton sensitivity of the CD41+ mpICs contained in RA SF presented as % of untreated (control) CD41+ mpICs.CC BY · PubMed Central
Figure 4 Platelet MPs form mpICs independently of CD32a A,B. The expression of CD32a by platelet MPs was determined by hs-FCM and Western blot analysis (inset in A). The platelet MPs were generated in vitro upon platelet GPVI stimulation (A) and the endogenous MPs in RA SF were detected using Annexin-V (B). Blue: isotype; grey: specific CD32a labeling (n = 3).C. FSC-PMT and SSC profiles of the fluorescent platelets (top panel) and platelet MPs (bottom panel) (n = 10). The relative dimensions are presented according to size-defined microsphere calibrations.D–G. Results obtained following the incubation of exogenous fluorescent platelet MPs in RA and PA SF (n = 10 RA and n = 18 PA). (D) Representative FSC-PMT and SSC plots obtained using RA (top) and PA SF (bottom). Two subpopulations (subpop) (1 and 2) were detected in RA and only one in PA SF (1). (E,F) hs-FCM evaluation of the presence of IgG on surface of MPs upon incubation in RA (E) and PA SF (F) using Cy5-conjugated anti-IgG antibody. The four-quadrant gates were positioned according to the isotypic controls. (E) MPs (in green) are IgG− and show dimensions ranging from 100 to 300 nm (lower inset) while the mpICs (in blue) have dimensions ranging from 700 to 3000 nm (upper inset). (D,E) The relative dimensions are presented according to size-defined microsphere calibrations. (G) hs-FCM quantifications of the mpICs were determined in absence (1st and 3rd column) or presence (2nd column) of CD32a blocking antibody (1st and 2nd column p = 0.4478 (unpaired t-test), 1st and 3rd column ***p < 0.0001). Statistical analyses are presented under the graphs. Data are mean ± SEM.
Figure 4 Platelet MPs form mpICs independently of CD32a A,B. The expression of CD32a by platelet MPs was determined by hs-FCM and Western blot analysis (inset in A). The platelet MPs were generated in vitro upon platelet GPVI stimulation (A) and the endogenous MPs in RA SF were detected using Annexin-V (B). Blue: isotype; grey: specific CD32a labeling (n = 3).C. FSC-PMT and SSC profiles of the fluorescent platelets (top panel) and platelet MPs (bottom panel) (n = 10). The relative dimensions are presented according to size-defined microsphere calibrations.D–G. Results obtained following the incubation of exogenous fluorescent platelet MPs in RA and PA SF (n = 10 RA and n = 18 PA). (D) Representative FSC-PMT and SSC plots obtained using RA (top) and PA SF (bottom). Two subpopulations (subpop) (1 and 2) were detected in RA and only one in PA SF (1). (E,F) hs-FCM evaluation of the presence of IgG on surface of MPs upon incubation in RA (E) and PA SF (F) using Cy5-conjugated anti-IgG antibody. The four-quadrant gates were positioned according to the isotypic controls. (E) MPs (in green) are IgG− and show dimensions ranging from 100 to 300 nm (lower inset) while the mpICs (in blue) have dimensions ranging from 700 to 3000 nm (upper inset). (D,E) The relative dimensions are presented according to size-defined microsphere calibrations. (G) hs-FCM quantifications of the mpICs were determined in absence (1st and 3rd column) or presence (2nd column) of CD32a blocking antibody (1st and 2nd column p = 0.4478 (unpaired t-test), 1st and 3rd column ***p < 0.0001). Statistical analyses are presented under the graphs. Data are mean ± SEM.CC BY · PubMed Central
Figure 5 Platelet MPs display citrullinated autoantigens recognized by IgG from RA SF A,B The presence of citrullinated epitopes on platelet MPs was determined by hs-FCM using anti-citrulline antibody and its corresponding secondary antibody conjugated to Alexa 647. MPs were confirmed of platelet origin using a PE-conjugated anti-CD41 antibody. (A) The presence of citrullinated antigens on platelet MPs was determined in in vitro platelet MPs (left panel) and MPs from RA SF (right panel). The vertical lines were positioned according to the isotypic controls. Pink: Negative population; blue: Positive population. The % of positive platelet MPs is indicated on graphs. (B) Quantification of the citrulline+ CD41+ MPs in RA and PA SF (n = 8 RA and n = 8 PA *p = 0.0148).C,D The proteins from platelet MPs obtained in vitro left unmodified (−PAD4) or citrullinated (+PAD4) were separated on SDS–PAGE and transferred to membranes. The membranes were incubated in presence of RA (C) or PA (D) SF and the recognition of MP-derived autoantigens by autoantibodies from SF was revealed using HRP-conjugated anti-human IgG. Arrows indicate proteins recognized by IgG from SF uniquely when the MPs were citrullinated. Two RA and PA SF are presented to illustrate the existing variability between patients (n = 12 RA and n = 8 PA).
Figure 5 Platelet MPs display citrullinated autoantigens recognized by IgG from RA SF A,B The presence of citrullinated epitopes on platelet MPs was determined by hs-FCM using anti-citrulline antibody and its corresponding secondary antibody conjugated to Alexa 647. MPs were confirmed of platelet origin using a PE-conjugated anti-CD41 antibody. (A) The presence of citrullinated antigens on platelet MPs was determined in in vitro platelet MPs (left panel) and MPs from RA SF (right panel). The vertical lines were positioned according to the isotypic controls. Pink: Negative population; blue: Positive population. The % of positive platelet MPs is indicated on graphs. (B) Quantification of the citrulline+ CD41+ MPs in RA and PA SF (n = 8 RA and n = 8 PA *p = 0.0148).C,D The proteins from platelet MPs obtained in vitro left unmodified (−PAD4) or citrullinated (+PAD4) were separated on SDS–PAGE and transferred to membranes. The membranes were incubated in presence of RA (C) or PA (D) SF and the recognition of MP-derived autoantigens by autoantibodies from SF was revealed using HRP-conjugated anti-human IgG. Arrows indicate proteins recognized by IgG from SF uniquely when the MPs were citrullinated. Two RA and PA SF are presented to illustrate the existing variability between patients (n = 12 RA and n = 8 PA).CC BY · PubMed Central
Figure 6 Platelet MPs in RA SF exhibit autoantigens A. Identification of the autoantibodies contained in CD41+ mpICs in RA SF. The binding specificity of the mpIC-eluted IgG to 40 antigens was determined on a Bio-Plex™ bead-based antigen array and only the antigens that presented significant binding are presented (n = 23 RA patients, identified 1–23). Colours denote amount of binding: undetectable (blue); progressively greater binding (green, yellow, red). Color scale is presented on right. The negative control (C) was obtained by incubating isotypic antibodies in SF. Cfc; cyclic citrullinated filaggrin, H2A/a; histone H2A/a.B–D. The presence of autoantigens was examined on in vitro platelet MPs (left) and platelet MPs from RA SF (right) by hs-FCM (n = 4). (B) MPs were incubated with anti-vimentin and the interaction was revealed using Alexa 647-conjugated secondary antibody. (C) MPs were incubated with exogenous Alexa 647-fluorescent fibrinogen and associations quantified by hs-FCM. (D) MPs were incubated with anti-fibrinogen and the interaction with endogenous fibrinogen was determined using Alexa 647-conjugated secondary antibody. The vertical lines were positioned according to the isotypic controls. Green: negative population; blue: positive population. The % of positive MPs is indicated on graphs.
Figure 6 Platelet MPs in RA SF exhibit autoantigens A. Identification of the autoantibodies contained in CD41+ mpICs in RA SF. The binding specificity of the mpIC-eluted IgG to 40 antigens was determined on a Bio-Plex™ bead-based antigen array and only the antigens that presented significant binding are presented (n = 23 RA patients, identified 1–23). Colours denote amount of binding: undetectable (blue); progressively greater binding (green, yellow, red). Color scale is presented on right. The negative control (C) was obtained by incubating isotypic antibodies in SF. Cfc; cyclic citrullinated filaggrin, H2A/a; histone H2A/a.B–D. The presence of autoantigens was examined on in vitro platelet MPs (left) and platelet MPs from RA SF (right) by hs-FCM (n = 4). (B) MPs were incubated with anti-vimentin and the interaction was revealed using Alexa 647-conjugated secondary antibody. (C) MPs were incubated with exogenous Alexa 647-fluorescent fibrinogen and associations quantified by hs-FCM. (D) MPs were incubated with anti-fibrinogen and the interaction with endogenous fibrinogen was determined using Alexa 647-conjugated secondary antibody. The vertical lines were positioned according to the isotypic controls. Green: negative population; blue: positive population. The % of positive MPs is indicated on graphs.CC BY · PubMed Central
Figure 7 Platelet mpICs promote leukotriene production by neutrophils Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of RA SF mpICs [n = 3 distinct patients ***p < 0.0001 patients 1 and 2; **p = 0.0011 patient 3 (unpaired t-test, relative to PBS control)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.Platelet mpICs form promptly upon co-incubation of platelet MPs with anti-fibrinogen in vitro. Representative FSC-PMT and SSC dot plot of mpICs. The presence of mpICs formed in vitro was demonstrated using a combination of FITC-conjugated Annexin-V and Alexa 647-conjugated secondary antibody. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) presented in blue show dimensions ranging mostly from 100 to 500 nm (lower inset) while the mpICs (Annexin-V+-IgG+) presented in purple display dimensions ranging from 800 to 3000 nm (upper inset). The relative dimensions are presented according to size-defined microsphere calibrations.Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of in vitro mpICs, anti-fibrinogen and platelet MPs. The stimulatory potency of mpICs compared to the others conditions was statistically significant [n = 3 ***p ≤ 0.0001 (unpaired t-test)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.
Figure 7 Platelet mpICs promote leukotriene production by neutrophils Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of RA SF mpICs [n = 3 distinct patients ***p < 0.0001 patients 1 and 2; **p = 0.0011 patient 3 (unpaired t-test, relative to PBS control)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.Platelet mpICs form promptly upon co-incubation of platelet MPs with anti-fibrinogen in vitro. Representative FSC-PMT and SSC dot plot of mpICs. The presence of mpICs formed in vitro was demonstrated using a combination of FITC-conjugated Annexin-V and Alexa 647-conjugated secondary antibody. The four-quadrant gates were positioned according to the isotypic controls. The MPs (Annexin-V+-IgG−) presented in blue show dimensions ranging mostly from 100 to 500 nm (lower inset) while the mpICs (Annexin-V+-IgG+) presented in purple display dimensions ranging from 800 to 3000 nm (upper inset). The relative dimensions are presented according to size-defined microsphere calibrations.Quantifications of the leukotriene biosynthesis by neutrophils incubated in presence of in vitro mpICs, anti-fibrinogen and platelet MPs. The stimulatory potency of mpICs compared to the others conditions was statistically significant [n = 3 ***p ≤ 0.0001 (unpaired t-test)]. Data are mean ± SEM. Leukotrienes measured represent the sum of LTB4, 6-trans-LTB4, 12-epi-6-trans-LTB4, 20-OH-LTB4 and 20-COOH-LTB4.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 73 references

Cited by

Items 201–254 of 254

Metadata

Authors
Cloutier, N., Tan, S., Boudreau, L. H., Cramb, C., Subbaiah, R., Lahey, L., Albert, A., Shnayder, R., Gobezie, R., Nigrovic, P. A., Farndale, R. W., Robinson, W. H., Brisson, A., Lee, D. M., & Boilard, E.
Affiliations
  • Centre hospitalier universitaire de Québec (CA)
  • Chimie et Biologie des Membranes et des Nanoobjects (FR)
  • Stanford Medicine (US)
  • Case Western Reserve University (US)
  • Brigham and Women's Hospital (US)
  • University Hospitals of Cleveland (US)
  • University of Cambridge (GB)
Venue
EMBO Molecular Medicine
Published
2012-12-11
Volume
5
Issue
2
Pages
235-249
ISSN
  • 1757-4676 (ISSN-L)
  • 1757-4684
OpenAlex
W2123391301
Cited by
254
References
72
Citations by year
2026: 6 · 2025: 10 · 2024: 14 · 2023: 18 · 2022: 27 · 2021: 21 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 23 · 2016: 27 · 2015: 22 · 2014: 6 · 2013: 7
FWCI
8.61
Type
journal article
Language
en
Open access
Licence
Locations
  • EMBO Molecular Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Arthritis Society
  • British Heart Foundation (RG/09/003/27122)
  • National Institutes of Health (5p01ai065858-05, AI065858)
  • Canadian Institutes of Health Research
  • National Institute of Allergy and Infectious Diseases (P01 AI-065858)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR065538)
  • Canadian Arthritis Network
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Keywords
microparticles, immune complexes, rheumatoid arthritis, platelets, autoantigens, vimentin, fibrinogen, anti-citrullinated protein antibodies, synovial fluid, CD41, FcγRIIa, neutrophil activation, leukotriene biosynthesis, inflammation, autoimmune arthritis, extracellular vesicles
MeSH terms
Antigen-Antibody Complex, Arthritis, Rheumatoid, Autoantigens, Humans, Particle Size, Synovial Fluid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.